Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

People In Brief

This article was originally published in The Tan Sheet

Executive Summary

CHPA associate counsel: Consumer Healthcare Products Association adds Alison Manhoff to its staff as associate general counsel. Manhoff has moved to the trade group from the Washington firm King and Spalding, where she worked as an FDA/healthcare associate. She started with CHPA Nov. 19 to provide legal analysis of key issues, assist with policy development, manage task group activities and provide internal legal support. Manhoff is a graduate of Vanderbilt University Law and is admitted to practice law in D.C. and California...

You may also be interested in...



NCCAM Director Aim For “Strong Portfolio” Of Studies Despite Funding Limits

National Center for Complementary and Alternative Medicines Director Josephine Briggs started in the post at a time when the center is expected to operate with no increase in federal funding, she says

NCCAM Director Aim For “Strong Portfolio” Of Studies Despite Funding Limits

National Center for Complementary and Alternative Medicines Director Josephine Briggs started in the post at a time when the center is expected to operate with no increase in federal funding, she says

NCCAM Director Aim For “Strong Portfolio” Of Studies Despite Funding Limits

National Center for Complementary and Alternative Medicines Director Josephine Briggs started in the post at a time when the center is expected to operate with no increase in federal funding, she says

Topics

UsernamePublicRestriction

Register

OM013164

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel